CBMED GMBH CENTER FOR BIOMARKER RES IN MEDICINE has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets measurement and biotechnology are PROKYMA TECHNOLOGIES LTD, BEIJING BEIER BIOENGINEERING CO LTD and INST AGRICULTURAL QUALITY STANDARD & INSPECTION TECHNOLOGY CHINA ACADEMY AGRICULTURAL SCI.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes | |
#3 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Olschewski Horst | 6 |
#2 | Krassnig Stefanie | 6 |
#3 | Gander Edgar | 6 |
#4 | Bordag Natalie | 6 |
#5 | Golob-Schwarzl Nicole | 6 |
#6 | Narath Sophie | 6 |
#7 | Haybaeck Johannes | 6 |
#8 | Olschewski Andrea | 6 |
#9 | Magnes Christoph | 6 |
#10 | Deutsch Alexander | 6 |
Publication | Filing date | Title |
---|---|---|
US2021054374A1 | Antitumor compounds and tumor diagnosis | |
WO2018024609A2 | Method for prognosing and diagnosing tumors | |
EP3431988A1 | Method to determine the state of the humoral immune system in a patient | |
EP3427064A1 | Biomarker for the diagnosis of pulmonary hypertension (ph) |